COMPARISON OF EFFECTS OF STANOZOLOL AND SUBCUTANEOUS HEPARIN ON COAGULATION AND FIBRINOLYSIS IN SURGICAL PATIENTS

被引:0
|
作者
PRESTON, FE
KLUFT, C
SIMMS, M
MALIA, RG
GREAVES, M
机构
[1] UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND
[2] TNO,GAUBIUS INST,LEIDEN,NETHERLANDS
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:31 / 31
页数:1
相关论文
共 50 条
  • [1] HEPARIN AND FIBRINOLYSIS - COMPARISON OF SUBCUTANEOUS ADMINISTRATION OF UNFRACTIONATED AND LOW-MOLECULAR WEIGHT HEPARIN
    ERIKSSON, E
    WOLLTER, IM
    CHRISTENSON, B
    STIGENDAL, L
    RISBERG, B
    [J]. THROMBOSIS AND HAEMOSTASIS, 1988, 59 (02) : 284 - 288
  • [2] STANOZOLOL-INDUCED CHANGES IN FIBRINOLYSIS AND COAGULATION IN HEALTHY-ADULTS
    KLUFT, C
    PRESTON, FE
    MALIA, RG
    BERTINA, RM
    WIJNGAARDS, G
    GREAVES, M
    VERHEIJEN, JH
    DOOIJEWAARD, G
    [J]. THROMBOSIS AND HAEMOSTASIS, 1984, 51 (02) : 157 - 164
  • [3] Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction
    Frostfeldt, G
    Gustavsson, G
    Lindahl, B
    Nygren, A
    Siegbahn, A
    Wallentin, L
    [J]. THROMBOSIS RESEARCH, 2002, 105 (03) : 193 - 199
  • [4] HEMOSTATIC EFFECTS OF UNIFORM, LOW-DOSE SUBCUTANEOUS HEPARIN IN SURGICAL PATIENTS
    GUREWICH, V
    NUNN, T
    KURIAKOSE, TTX
    HUME, M
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (01) : 41 - 44
  • [5] Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction
    Soejima, H
    Ogawa, H
    Suefuji, H
    Kaikita, K
    Takazoe, K
    Miyamoto, S
    Kajiwara, I
    Shimomura, H
    Sakamoto, T
    Yoshimura, M
    Nakamura, S
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (12): : 1408 - 1411
  • [6] Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism
    Minnema, MC
    tenCate, H
    vanBeek, EJR
    vandenEnde, A
    Hack, CE
    Brandjes, DPM
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, 77 (06) : 1164 - 1167
  • [7] SUBCUTANEOUS HEPARIN IN PREVENTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN PATIENTS WITH SERIOUS INFECTIONS
    ZAWILSKA, K
    KOMARNICKI, M
    PSUJA, P
    SOWIER, J
    KAWCZYNSKI, S
    WYSOCKI, K
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 397 - 397
  • [8] INTRAVENOUS HEPARIN VERSUS SUBCUTANEOUS HEPARIN IN SURGICAL INTENSIVE CARE UNIT PATIENTS
    Cheng, Sara
    Brown, Samuel
    Grissom, Colin
    Morris, Peter
    Malik, Rajesh
    Pittman, Joel
    Dean, Nathan
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (12) : U229 - U229
  • [9] GOAL-DIRECTED INTRAVENOUS HEPARIN, BUT NOT SUBCUTANEOUS HEPARIN, NORMALIZES COAGULATION STATUS IN SICU PATIENTS
    Baer, A.
    Hamiel, C.
    Cheng, S.
    Luzier, E.
    Pearlman, N.
    Wischmeyer, P. E.
    [J]. SHOCK, 2010, 33 : 29 - 30
  • [10] GOAL-DIRECTED INTRAVENOUS HEPARIN, BUT NOT SUBCUTANEOUS HEPARIN, NORMALIZES COAGULATION STATUS IN SICU PATIENTS
    Hamiel, Christine
    Baer, Angie
    Luzier, Elizabeth
    Cheng, Sara
    Pearlman, Nathan
    Wischmeyer, Paul
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (12) : A425 - A425